CAV1 plays a central role in radioresistance‐mediated tumour‐stroma interactions in advanced prostate cancer (PCa), CAV1‐deficient endothelial cells increased growth delay of PCa cell after radiation treatment.65 Here, CAV1 is linked to prostate cancer.